Researchers found that even in bacteria that already had drug resistance genes, sequential treatments could be used to kill the bacteria. Sequential treatments didn’t suppress the rise of all drug resistance mutations in the bacteria, however one drug would ‘sensitize’ the bacteria to the second drug, and thereby reduce the risk of drug resistance.
“One outcome of this highly surprising result will be to set in motion a series of studies to determine ways of using antibiotics not only in combination, but sequentially and with the potential for lower dosages than is currently thought possible,” said Researcher Jessica Plucain, PhD.
More articles on ASC issues:
7 things for ASC leaders to know for Thursday – April 9, 2015
5 tips to fix ASC supply chain failures
1st AAAHC-accredited periodontal surgery center opens in Illinois
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
